Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Pharmaceutical Research and Manufacturers of America
Pharmaceutical Research and Manufacturers of America
Activities:
Media
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Regulatory
PhRMA board talk with President Trump
PhRMA CEO has issued a statement following his meeting with President Trump regarding the US biopharmaceutical industry
Research & Development
PhRMA member companies invested US$58.8bn in R&D in 2015
Biopharmaceutical industry continues to be most R&D-intensive industry in US economy
You need to be a subscriber to read this article.
Click here
to find out more.
Finance
TPP agreement – a bitter pill to swallow?
US negotiatiors have had to make concessions over biologics protection to secure a Trans-Pacific Partnership (TPP) deal, but health campaigners are unimpressed
Research & Development
PhRMA reports 836 medicines and vaccines in development to treat cancer
Building on decades of progress in the fight against the disease, a robust pipeline of potential new treatments sustains hope for patients and their families
Regulatory
US pharma associations clash over Trans-Pacific Partnership (TPP)
After President Obama secures trade promotion authority powers
Regulatory
Sanofi to expand access to clinical trial data
In support of PhRMA and EFPIA principles on responsible sharing of data
Finance
PhRMA sounds alarm over US budget cuts
Criticises proposal on generics
Subscribe now